Comparison of the new polyethersulfone high-flux membrane DIAPES Õ HF800 with conventional high-flux membranes during on-line haemodiafiltration
|
|
- Shawn Conley
- 6 years ago
- Views:
Transcription
1 Nephrol Dial Transplant (2003) 18: DOI: /ndt/gfg410 Original Article Comparison of the new polyethersulfone high-flux membrane DIAPES Õ HF800 with conventional high-flux membranes during on-line haemodiafiltration Walter Samtleben 1, Christina Dengler 1, Birgit Reinhardt 2, Annekatrin Nothdurft 2 and Horst-Dieter Lemke 2 1 Department of Nephrology, University Hospital Munich-Grosshadern, Munich and 2 Membrana Research, Obernburg, Germany Abstract Background. Current modalities of renal replacement therapy allow only a limited removal of larger, possibly toxic molecules, which accumulate in uraemia. Recently, a haemodiafilter has been made available with the new, high-flux, polyethersulfone-based membrane DIAPES Õ HF800. We performed a study to compare DIAPES Õ HF800 with two conventional high-flux membranes in on-line haemodiafiltration (HDF), with respect to the removal properties for the two marker proteins, 2 -microglobulin ( 2 m, 11.8 kda) and albumin (66.5 kda). Methods. In a prospective, controlled study 10 stable end-stage renal disease patients were randomly allocated to 30 sessions of post-dilutional on-line HDF with three types of steam-sterilized membranes: DIAPES Õ HF800, polysulfone and polyamide. Blood flow rate was 250 ml/min and treatment time was 240 min. Pre-treatment 2 m and albumin plasma concentrations did not differ between the three groups. The concentration of the two proteins was determined before and after treatment in plasma as well as in the continuously collected haemodiafiltrate. Results. Tolerance of all treatments was very good, without any side-effects for all filters. The mean plasma reduction rate of 2 m was 77 ± 1% for DIAPES Õ HF800 and polysulfone whereas it was 71 ± 1% for polyamide (P < 0.05). The mean 2 m amount removed and found in the haemodiafiltrate per session was 230 ± 14 mg for DIAPES Õ HF800, 186 ± 13 mg for polysulfone and 147 ± 13 mg for polyamide (P < 0.05 between each pair of membranes). The same ranking was obtained for albumin removed and found in haemodiafiltrate per session for the three membranes: 5.7 ± 0.4, 3.5 ± 0.4 and 1.0 ± 0.4 g, respectively. Correspondence and offprint requests to: Horst-Dieter Lemke, Forschungsstrasse, Membrana GmbH, D Obernburg, Germany. horstdieter.lemke@membrana.de Although DIAPES Õ HF800 showed the highest value for albumin in haemodiafiltrate the mean posttreatment plasma albumin was higher after the treatment with DIAPES Õ HF800 compared with the other membranes (P < 0.05). Conclusions. On-line HDF has shown to achieve plasma reduction rates for 2 m of up to 77% for the DIAPES Õ HF800 membrane and for polysulfone. The amounts of 2 m and albumin in haemodiafiltrate were much higher for DIAPES Õ HF800 than for the other two membranes indicating a greater permeability for molecules up to a molecular weight of 66.5 kda. This could, at least theoretically, offer the advantage also to remove uraemic toxins in the molecular weight range of albumin or of albumin-bound toxins. The future must show whether this will counterbalance the loss of albumin. Keywords: albumin; 2 -microglobulin; haemodiafiltration; high-flux membrane; polyethersulfone; post-dilution Introduction The introduction of a newly developed, highly permeable haemodialysis (HD) membrane arises interest in today s nephrological community. The question is often considered as to whether a membrane with higher permeability may fulfil an improved balance between a higher removal of uraemic toxins in the molecular weight range from urea to small proteins such as 2 -microglobulin ( 2 m) and a clinically tolerable albumin loss. In recent years, the choice of membranes of either synthetically modified cellulosic or synthetic membranes has expanded to a large extent. In parallel, a trend towards treatment modes with higher plasma reduction rates has recently been Nephrol Dial Transplant 18(11) ß ERA EDTA 2003; all rights reserved
2 Comparison of DIAPES Õ HF800 and conventional high-flux membranes during HDF 2383 Table 1. Characteristics of treatment parameters DIAPES Õ HF800 Polysulfone Polyamide S Õ Membrane manufacturer Membrana Fresenius Gambro Haemodiafilter BLS819SD HF80S Polyflux Õ 17S Manufacturer Bellco Fresenius Gambro Membrane surface area 1.8 m m m 2 Number of patients 9 a Treatment time (min) 240 ± ± ± 0 Q B (ml/min) 250 ± ± ± 0 Q out (l/4 h) ± ± ± 0.7 UF volume (Weight loss) (l/4 h) 3.38 ± ± ± 0.71 Substitution fluid volume (l/4 h) 14.6 ± ± ± 0.7 a One drop-out. witnessed [1,2]. The reason for such a trend may be derived from a revived interest in the field of uraemic toxins. Apart from being small, dialysable molecular substances, uraemic toxins may be bound to plasma proteins such as albumin or can be proteins itself, like 2 m (11.8 kda). The removal of plasma proteins up to the 66.5 kda range of albumin has been investigated by several authors employing different membranes and dialysis modalities [3 5]. The factors involved in the removal of low molecular weight proteins depend not only on membrane permeability, but also on the transmembrane pressure applied during treatment [6] and on patient specific variables. Recently, DIAPES Õ HF800, a highly permeable membrane made of polyethersulfone (PES) has been developed. DIAPES Õ HF800 exhibits an increased hydraulic permeability compared with conventional high-flux membranes. This leads to an in vitro ultrafiltration rate of 80 ml/h mmhg for DIAPES Õ HF800 in the BLS819SD haemodiafilter (Bellco) compared with 55 ml/h mmhg for the polysulfone membrane in the Hemoflow Õ HF80S (Fresenius Medical Care). In this study, we evaluated the removal of 2 m and albumin in patients undergoing postdilutional on-line haemodiafiltration (HDF) using DIAPES Õ HF800 in comparison with two other synthetic membranes. Subjects and methods Patients The study was prospective, randomized and cross-over in nature and the study protocol was approved by the local ethics committee. Ten chronic uraemic patients on a regular thrice weekly HD programme were enrolled after giving informed consent [seven males, three females; aged 51 ± 13 years (range years); 42 ± 37 months on dialysis (range months)]. The patients were randomly treated once with DIAPES Õ HF800 (Membrana GmbH, Wuppertal, Germany; BLS819SD, 1.8 m 2, steam-sterilized, Bellco S.p.A., Mirandola, Italy), and once with polyamide (Polyflux Õ 17S, Gambro, Lund, Sweden) and polysulfone (Hemoflow Õ HF80S, Fresenius Medical Care, Bad Homburg, Germany), respectively, in a 4-h post-dilutional on-line HDF regime (Gambro AK100 Ultra monitor). Treatments under investigation were once a week after the long dialysis-free interval. Details of the HDF treatment parameters and of the haemodiafilters are listed in Table 1. One patient had to be admitted to the hospital after the second study treatment for reasons, which were not related to the study. As a consequence, one treatment with DIAPES Õ HF800 could not be performed. Determination of albumin and 2 m In order to study the removal of 2 m and albumin with the haemodiafiltrate, a T-connector was introduced into the effluent haemodiafiltrate line allowing continuous collection of haemodiafiltrate at a flow rate of 1 ml/min into a separate beaker during the entire duration of the treatment (Figure 1). Samples were drawn from this haemodiafiltrate pool after each hour of treatment. Before sampling, the pool was mixed well by a magnetic stirrer. The mass of solute transferred to the haemofiltrate after a given time t was calculated from: mass of solute ¼ Q out * t * c t where Q out is the outlet haemofiltrate flow rate, consisting of the dialysate flow rate Q dial/in, the substitution fluid flow rate Q sub and the net ultrafiltration flow rate Q UF as shown in Figure 1. c t is the concentration of the solute in the cumulated haemodiafiltrate pool after time t. The plasma levels of 2 m and albumin were measured directly before (pre, t ¼ 0) and after (post, t ¼ 240 min) the treatment. 2 m and albumin in haemodiafiltrate and in plasma were measured by laser nephelometry (BN 100 Analyzer, Dade-Behring Marburg GmbH, Marburg, Germany) using N Latex 2 -microglobulin and N Antiserum to human albumin (Dade-Behring Marburg GmbH), respectively. The 2 m post-haemodiafilter concentration was corrected for haemoconcentration according to Bergstrom and Wehle [7]. Statistics Differences between parameters were tested by multivariate ANOVA and Duncan s multiple range test. A P value of <0.05 was considered significant. Results are given as mean of all treatments ± SEM.
3 2384 W. Samtleben et al. Fig. 1. HDF set-up and haemodiafiltrate collection scheme. Table 2. 2 M, albumin and blood pressure pre- and post-hdf (mean ± SEM) Results The absolute amount of 2 m and of albumin detectable at the end of the treatment in the cumulative haemodiafiltrate pool as well as the pre- and posttreatment plasma values for albumin are shown in Table 2. Both total 2 m and total albumin found in the haemodiafiltrate decreased in the sequence DIAPES Õ HF800 > polysulfone > polyamide. There was a significant difference for both, 2 m and albumin in the haemodiafiltrate between the three membranes. All other data, especially the respective pre-treatment values, showed no significant differences between the three membranes. While the DIAPES Õ HF800 haemodiafilter reduced the plasma 2 m level by 77 ± 1% of the pre-dialysis value (identical to the reduction with polysulfone), polyamide achieved only a reduction rate of 71 ± 1% (P < 0.05) as shown in Figure 2. The amount of 2 m in haemodiafiltrate corresponded with the amount of albumin in haemodiafiltrate. All membranes showed an increase of the DIAPES Õ HF 800 Polysulfone Õ Polyamide S Õ 2 m in haemodiafiltrate (mg) 230±14 a 186±13 a 147±13 a Albumin in haemodiafiltrate (g) 5.7±0.4 a 3.5±0.4 a 1.0±0.4 a Plasma albumin concentration pre-hdf (g/l) 35.8± ± ±0.4 Plasma albumin concentration post-hdf (g/l) 43.4±0.6 b 40.9± ±0.5 Systolic/diastolic blood pressure (mmhg) pre-hdf 146±9/86±4 142±7/78±5 137±7/78±5 Systolic/diastolic blood pressure (mmhg) post-hdf 123±8/81±5 134±9/79±4 130±11/79±5 a Significantly different from each other (P < 0.05). b Significantly different from polysulfone and polyamide S Õ (P < 0.05). albumin concentration in haemodiafiltrate during the last 2 h of treatment. Pre-dialysis plasma albumin values and ultrafiltration volumes were comparable for the three membranes, the latter despite the fact that in all cases the ultrafiltration rates were set individually in order to achieve the patients dry weights (see Table 1). Although DIAPES Õ HF800 showed the highest albumin loss into haemodiafiltrate, interestingly, the post-dialysis plasma albumin level after the DIAPES Õ HF800 treatments was significantly higher compared with the other two haemodiafilters (Table 2). Discussion Treatments with DIAPES Õ HF800 used in the HDF mode were tolerated very well without any side-effects and did not differ in this regard from those with established membranes. Average blood pressure was slightly increased before and normalized during treatments in all three groups as expected. Blood and
4 Comparison of DIAPES Õ HF800 and conventional high-flux membranes during HDF 2385 Fig. 2. Plasma concentrations and plasma reduction rates (RR) of 2 m during post-dilutional on-line HDF for three different membranes (mean ± SEM). The plasma reduction rate for 2 m of polyamide is significantly lower (P < 0.05) compared with the other two membranes (*). The post values of each membrane group are significantly different (P < 0.05) from pre values (**). haemodiafiltrate flow rates, ultrafiltration and infusion volumes, pre-treatment 2 m and albumin concentrations were not significantly different between the three membranes under investigation. Therefore, these factors did neither influence the removal of 2 m nor of albumin during treatment. In conventional HD with high-flux polysulfone and a blood flow of 300 ml/min a 2 m plasma reduction rate of 50% has been reported whereas on-line HDF in post-dilution mode with 100 ml/min substitution fluid resulted in a reduction rate of 73% [8]. With a substitution rate of 120 ml/min and a blood flow of 350 ml/min 2 m plasma reduction rate could not be raised further [8]. In our study, a higher 2 m plasma reduction rate was observed for both DIAPES Õ HF800 and polysulfone with a substitution fluid flow rate of only 60 ml/min and a blood flow of only 250 ml/min. In another report on conventional HDF (22 ml/min substitution flow rate, 402 ml/min blood flow rate) and for online HDF (120 ml/min, 434 ml/min) using polysulfone as well as AN69 Õ membranes a removal rate of 2 m from plasma of 56 and 71% was observed, respectively [2]. On the other hand, during high-flux HD with a blood flow of 250 ml/min using a variety of synthetic membranes (Asahi PAN DX-85, Nikkiso FLX-15GW, Renal Systems Primus 2000, Althin Medical Altra-Flux 170G) lower amounts (between 80 and 170 mg) of 2 m compared with our study (e.g. 230 ± 14 mg with DIAPES Õ HF 800) were measured in dialysate [9,10]. In uraemia, the correlation between hypoalbuminaemia and higher morbidity and mortality is a well-documented fact [11]. In peritoneal dialysis with a mean albumin loss of g/day, patients with high peritoneal transport displayed lower serum albumin levels and a lower survival compared with patients with a lower peritoneal permeability [12]. Serum albumin levels, however, are influenced by several different factors such as age, nutritional status, inflammation, plasma volume expansion and decreased protein synthesis, the latter possibly related to inflammation. Some studies make the peritoneal loss of albumin responsible for hypoalbuminaemia [12]. On the contrary, as shown recently, CAPD patients with normal albumin, lose more albumin into dialysate compared with hypoalbuminaemic patients. Reduction of plasma albumin was only observed in those patients having a reduced protein catabolic rate even without overt inflammation [13]. In our HDF study, albumin loss was lowest with polyamide (1.0 ± 0.7 g/session), intermediate with polysulfone (3.5 ± 1.4 g/session) and highest with the DIAPES Õ HF800 membrane (5.7 ± 1.4 g/session). To operate the HDF process under stable conditions during the entire session in all patients, we choose a blood flow rate of 250 ml/min and limited the filtration/substitution volume to 60 ml/min. If the membranes, however, will be used at higher blood flow rates and substitution volumes albumin loss will presumably increase. A previous study from an Italian group with two different PMMA membrane-based filters, even in HD mode, which is prone to a reduced loss of albumin compared with HDF, revealed a higher loss of albumin compared with the three filters we have examined (Filtryzer BK-P, 5.9 g/session; BK-F, 7.4 g/session, Toray, Tokyo, Japan) [4]. In another study with the Filtryzer BK-F, the dialyser with the highest loss of albumin reported to date, after 6 months of HD the plasma albumin level returned to 3.7 ± 0.2 g/dl after an initial drop. In parallel, renal anaemia improved [5]. It was hypothesized that enhanced removal of some compounds of higher molecular weight (probably having a molecular weight of 40 kda), exerting an inhibitory effect on erythroid progenitors, could be responsible [14]. Our study shows that with the three membranes DIAPES Õ HF800, polysulfone and polyamide, 2 m removal into haemodiafiltrate was directly related to albumin loss (Table 2). Thus, a higher loss of albumin
5 2386 W. Samtleben et al. seems to be unavoidable to remove more effectively certain uraemic toxins, e.g. proteins with a molecular weight higher than 2 m [5]. In our study, a loss of albumin with DIAPES Õ HF800 higher than with the two other membranes was not associated with a decrease of post-treatment albumin concentration. Provided a sufficient dietary protein intake, a loss of 6 g albumin/treatment in patients free of symptoms of inflammation can probably be tolerated as it will be compensated by enhanced albumin synthesis. However, these questions need to be addressed in a separate, long-term study [15]. Taking into account the two aspects of excellent low molecular weight clearances and the high permeability for low molecular weight proteins (indicated by the high 2 m in haemodiafiltrate), a general conclusion regarding serum albumin levels, treatment conditions and patient s risk cannot be made at the present time. Although, DIAPES Õ HF800 in HDF mode appears to offer a valuable alternative to conventional membranes long-term experience with this new membrane is needed to show whether its higher removal capacity for low molecular weight proteins is associated with additional clinical benefit. Conflict of interest statement. B. Reinhardt, A. Northdurft and H.-D. Lemke were at the time of the study employed by Membrana GmbH, the manufacturer of DIAPES Õ HF800. References 1. Canaud B, Bosc JY, Leray H et al. On-line haemodiafiltration: state of the art. Nephrol Dial Transplant 1998; 13 [Suppl 5]: Maduell F, del Pozo C, Garcia H et al. Change from conventional haemodiafiltration to on-line haemodiafiltration. Nephrol Dial Transplant 1999; 14: Kabanda A, Jadoul M, Pochet JM et al. Determinants of serum concentrations of low molecular weight proteins in patients on maintenance hemodialysis. Kidney Int 1994; 45: Bonomini M, Fiederling B, Bucciarelli T, Manfrini V, Di Ilio C, Albertazzi A. A new polymethacrylate membrane for hemodialysis. Int J Artif Organs 1996; 19: Buoncristiani U, Galli F, Benedetti S, Bianchi J, Floridi A, Canestrari F. Dramatic improvement of uremic anemia over a 6-month treatment with protein-leaking dialysers. J Am Soc Nephrol 2000; 11: 259A (Abstract) 6. Colton CK, Henderson LW, Ford CA, Lysaght MJ. Kinetics of hemodiafiltration. I. In vitro transport characteristics of a hollow-fiber blood ultrafilter. J Lab Clin Med 1975; 85: Bergstrom J, Wehle B. No change in corrected 2 -microglobulin concentration after Cuprophan hemodialysis. Lancet 1987; 1: Lornoy W, Becaus I, Billiouw JM, Van Malderen P, D Haenens P. On-line haemodiafiltration. Remarkable removal of 2 -microglobulin. Long term clinical observation. Nephrol Dial Transplant 2000; 15 [Suppl 1]: Sombolos K, Tsitamidou Z, Kyriazis G, Karagianni A, Kantaropoulou M, Progia E. Clinical evaluation of four different high-flux hemodialysers under conventional conditions in vivo. Am J Nephrol 1997; 17: Hoenich NA, Stamp S. Clinical performance of a new high-flux synthetic membrane. Am J Kidney Dis 2000; 36: Leavey SF, Strawderman RL, Jones CA, Port FK, Held PJ. Simple nutritional indicators as independent predictors of mortality in hemodialysis patients. Am J Kidney Dis 1998, 31: Churchill DN, Thorpe KE, Nolph KD, Keshaviah PR, Oreopoulos DG, Pagé D for the Canada-USA (CANUSA) Peritoneal Dialysis Study Group: increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. J Am Soc Nephrol 1998; 9: Caravaca F, Arrobas M, Dominguez C. Serum albumin and other serum protein fractions in stable patients on peritoneal dialysis. Perit. Dial Int 2000; 20: Yamada S, Kataoka H, Kobayashi H, Ono T, Minakuchi J, Kawano Y. Identification of an erythropoietic inhibitor from the dialysate collected in the haemodialysis with PMMA membrane (BK-F). Contrib Nephrol 1999; 125: Krieter DH, Canaud B. High permeability of dialysis membranes: what is the limit of albumin loss? Nephrol Dial Transplant 2003; 18: Received for publication: Accepted in revised form:
Dialysers Increasing Cost and Treatment Efficiency
Haemodialysis Dialysers Increasing Cost and Treatment Efficiency Fluid Substitution Calculator Content Haemodialysis yesterday 3 Haemodialysis today 4 Dialyser selection criteria 5 Relation of blood flow
More informationHemodiafiltration in Europe : Trends, Practices, Outcomes & Perspectives
Hemodiafiltration in Europe : Trends, Practices, Outcomes & Perspectives Prof. Bernard Canaud Nephrology, Dialysis and Intensive Care Lapeyronie Hospital CHRU Montpellier - France Opening remarks and special
More informationReverse mid-dilution: new way to remove small and middle molecules as well as phosphate with high intrafilter convective clearance
Nephrol Dial Transplant (2007) 22: 2000 2005 doi:10.1093/ndt/gfm101 Advance Access publication 3 April 2007 Original Article Reverse mid-dilution: new way to remove small and middle molecules as well as
More informationComparison of removal capacity of two consecutive generations of high-flux dialysers during different treatment modalities
Nephrol Dial Transplant (2011) 26: 2624 2630 doi: 10.1093/ndt/gfq803 Advance Access publication 10 February 2011 Comparison of removal capacity of two consecutive generations of high-flux dialysers during
More informationINSPIRED BY LIFE B. BRAUN DIALYZERS
INSPIRED BY LIFE B. BRAUN DIALYZERS OUR COMMITMENT. FOR LIFE. The Diacap Pro and xevonta dialyzers offer a broad range of high-quality dialyzers for individual treatment needs. It began in 1839, inspired
More informationSolute clearances during continuous venovenous haemofiltration at various ultrafiltration flow rates using Multiflow-100 and HF1000 filters
Nephrol Dial Transplant (2003) 18: 961 966 DOI: 10.1093/ndt/gfg055 Original Article Solute clearances during continuous venovenous haemofiltration at various ultrafiltration flow rates using Multiflow-100
More informationEarly Estimation of High Peritoneal Permeability Can Predict Poor Prognosis for Technique Survival in Patients on Peritoneal Dialysis
Advances in Peritoneal Dialysis, Vol. 22, 2006 Hidetomo Nakamoto, 1,2 Hirokazu Imai, 2 Hideki Kawanishi, 2 Masahiko Nakamoto, 2 Jun Minakuchi, 2 Shinichi Kumon, 2 Syuichi Watanabe, 2 Yoshhiko Shiohira,
More informationClinical cross-over comparison of mid-dilution hemodiafiltration. using a novel dialyzer concept and post-dilution hemodiafiltration.
Kidney International, Vol. 67 (2005), pp. 349 356 Clinical cross-over comparison of mid-dilution hemodiafiltration using a novel dialyzer concept and post-dilution hemodiafiltration DETLEF H. KRIETER,
More informationHDx THERAPY. Enabled by. Making possible personal.
HDx THERAPY Enabled by Making possible personal. THE NEXT HORIZON IN DIALYSIS IS CLOSER THAN YOU THINK PHOSPHATE UREA HDx BY THERANOVA EXPANDS YOUR RENAL POSSIBILITIES The new HDx therapy (expanded HD)
More informationUNDERSTANDING THE CRRT MACHINE
UNDERSTANDING THE CRRT MACHINE Helen Dickie Renal Sister Critical Care Unit Guy s and St.Thomas NHS Foundation Trust 18.10.14 RRT options - IHD vs CRRT (1) Intermittent HaemoDialysis e.g. 4hrs daily or
More informationMaking possible personal.
Making possible personal. HDX THERAPY, ENABLED BY THE THERANOVA DIALYZER HDF PERFORMANCE AND BEYOND AS SIMPLE AS HD The THERANOVA dialyzer, featuring an innovative membrane, effectively targets large middle
More informationFX classix High-Flux Dialysis for Improved Survival
Cardioprotective Haemodialysis FX classix High-Flux Dialysis for Improved Survival Cardioprotective HaemodialysisSP T Protect your Patient Cardioprotective Haemodialysis Wide-ranging cardioprotection The
More informationPART ONE. Peritoneal Kinetics and Anatomy
PART ONE Peritoneal Kinetics and Anatomy Advances in Peritoneal Dialysis, Vol. 22, 2006 Paul A. Fein, Irfan Fazil, Muhammad A. Rafiq, Teresa Schloth, Betty Matza, Jyotiprakas Chattopadhyay, Morrell M.
More informationPresent evidence on online hemodiafiltration.
Present evidence on online hemodiafiltration. Peter J. Blankestijn Department of Nephrology, Center Circulatory Health, University Medical Center Utrecht, The Netherlands Outline of presentation Basic
More informationAdvances in Peritoneal Dialysis, Vol. 23, 2007
Advances in Peritoneal Dialysis, Vol. 23, 2007 Antonios H. Tzamaloukas, 1,2 Aideloje Onime, 1,2 Dominic S.C. Raj, 2 Glen H. Murata, 1 Dorothy J. VanderJagt, 3 Karen S. Servilla 1,2 Computation of the Dose
More informationKaren Mak R.N. (Team Leader) Renal Dialysis Centre Hong Kong Sanatorium & Hospital
Karen Mak R.N. (Team Leader) Renal Dialysis Centre Hong Kong Sanatorium & Hospital - Renal Transplantation - Peritoneal Dialysis - Extracorporeal Therapy Extracorporeal Therapy It is the procedure in
More informationEnhancement of convective transport by internal filtration in a modified experimental hemodialyzer Technical Note
Kidney International, Vol. 54 (1998), pp. 979 985 Enhancement of convective transport by internal filtration in a modified experimental hemodialyzer Technical Note CLAUDIO RONCO, GIANCARLO ORLANDINI, ALESSANDRA
More informationUtilizzo di nuove membrane in HDF on-line con alto volume di scambio
Utilizzo di nuove membrane in HDF on-line con alto volume di scambio Antonio Bellasi, MD, PhD U.O.C. Nefrologia & Dialisi ASST-Lariana, Ospedale S. Anna, Como, Italy Disclosures The views expressed in
More informationHemodiafiltration: practical points. Rukshana Shroff Great Ormond Street Hospital for Children London, UK
Hemodiafiltration: practical points Rukshana Shroff Great Ormond Street Hospital for Children London, UK Effectiveness of RRT modalities Mcfarlane, Seminars in dialysis, 2009 No benefit from increased
More informationHaemodiafiltration: Present time technical, clinical, and financial issues
EDITORIAL Advance Access publication 22 May 2015 Haemodiafiltration: Present time technical, clinical, and financial issues Bernard Canaud 1,3, Laura Scatizzi 2, Aileen Grassmann 2, Daniele Marcelli 2
More informationHEMODIAFILTRATION PRINCIPLES AND ADVANTAGES OVER CONVENTIONAL HD PRESENTATION BY DR.ALI TAYEBI
HEMODIAFILTRATION PRINCIPLES AND ADVANTAGES OVER CONVENTIONAL HD PRESENTATION BY DR.ALI TAYEBI high-flux Hemodiafiltration (HDF) Combination of two dialysis techniques, hemodialysis and hemofiltration:
More informationHEMODIALFILTRATION LITERATURE REVIEW AND PRACTICE CONSIDERATIONS 1.0 PRACTICE CONSIDERATIONS 2.0 CURRENT LITERATURE REVIEW
HEMODIALFILTRATION LITERATURE REVIEW AND PRACTICE CONSIDERATIONS This document was prepared at the request of the BC Hemodialysis Committee to provide a brief overview of the literature and to identify
More informationNew method of blood purification (Recycle Filtration System)
Tokai J Exp Clin Med., Vol. 33, No. 3, pp. 124-129, 2008 New method of blood purification (Recycle Filtration System) Hajime SUZUKI 1), Miho HIDA 1), Makoto KITAMURA 1), Shin-ichi TANAKA 2), Takayo MIYAKOGAWA
More informationChapter 8 Online Hemodiafiltration by Fresenius Medical Care
Chapter 8 Online Hemodiafiltration by Fresenius Medical Care Bernard Canaud, Pascal Kopperschmidt, Reiner Spickermann, and Emanuele Gatti Abstract Hemodiafiltration has been identified by Fresenius Medical
More informationThe CARI Guidelines Caring for Australians with Renal Impairment. Mode of dialysis at initiation GUIDELINES
Date written: September 2004 Final submission: February 2005 Mode of dialysis at initiation GUIDELINES No recommendations possible based on Level I or II evidence SUGGESTIONS FOR CLINICAL CARE (Suggestions
More informationOnline Haemodiafiltration
The 20th Budapest Nephrology School August, 30,2013 Online Haemodiafiltration is it really the Technique of the Future? Prof. Francesco Locatelli MD FRCP Department of Nephrology, Dialysis and Renal Transplant
More informationOxalate clearance by haemodialysis a comparison of seven dialysers
Nephrol Dial Transplant (2005) 20: 1916 1921 doi:10.1093/ndt/gfh971 Advance Access publication 5 July 2005 Original Article Oxalate clearance by haemodialysis a comparison of seven dialysers Casper F.
More informationPhysiology of Blood Purification: Dialysis & Apheresis. Outline. Solute Removal Mechanisms in RRT
Physiology of Blood Purification: Dialysis & Apheresis Jordan M. Symons, MD University of Washington School of Medicine Seattle Children s Hospital Outline Physical principles of mass transfer Hemodialysis
More informationThe CARI Guidelines Caring for Australians with Renal Impairment. Monitoring patients on peritoneal dialysis GUIDELINES
Date written: August 2004 Final submission: July 2005 Monitoring patients on peritoneal dialysis GUIDELINES No recommendations possible based on Level I or II evidence SUGGESTIONS FOR CLINICAL CARE (Suggestions
More informationHaemodiafiltration - the case against. Prof Peter G Kerr Professor/Director of Nephrology Monash Health
Haemodiafiltration - the case against Prof Peter G Kerr Professor/Director of Nephrology Monash Health Know your opposition.. Haemodiafiltration NB: pre or post-dilution What is HDF how is it different
More informationEvaluation and management of nutrition in children
Evaluation and management of nutrition in children Date written: May 2004 Final submission: January 2005 Author: Elisabeth Hodson GUIDELINES No recommendations possible based on Level I or II evidence
More information3/21/2017. Solute Clearance and Adequacy Targets in Peritoneal Dialysis. Peritoneal Membrane. Peritoneal Membrane
3/21/2017 Solute Clearance and Adequacy Targets in Peritoneal Dialysis Steven Guest MD Director, Medical Consulting Services Baxter Healthcare Corporation Deerfield, IL, USA Peritoneal Membrane Image courtesy
More informationAcid base homeostasis with the high convective dialysis treatments
Nephrol Dial Transplant (2003) 18 [Suppl 7]: vii26 vii30 DOI: 10.1093/ndt/gfg1075 Acid base homeostasis with the high convective dialysis treatments Mariano Feriani Department of Nephrology and Dialysis,
More informationThe Role of Dialyzers in Cardiac Protection. Prof. Dr. Eng. Jörg Vienken BioSciences, Fresenius Medical Care, Bad Homburg, Germany
The Role of Dialyzers in Cardiac Protection Prof. Dr. Eng. Jörg Vienken BioSciences, Fresenius Medical Care, Bad Homburg, Germany With a Sense for Details! 1999 Peter Vienken, 11 years Prof. Pim Kolff,
More informationDiacap. Constant performance resulting in high quality dialysis. Avitum
Diacap Constant performance resulting in high quality dialysis Avitum B. Braun Avitum. Always with Passion. B. Braun is a leading international company in the healthcare market. With a long tradition stretching
More informationDialysis Adequacy (HD) Guidelines
Dialysis Adequacy (HD) Guidelines Peter Kerr, Convenor (Monash, Victoria) Vlado Perkovic (Camperdown, New South Wales) Jim Petrie (Woolloongabba, Queensland) John Agar (Geelong, Victoria) Alex Disney (Woodville,
More informationEFFECT OF ONLINE HAEMODIAFILTRATION ON ALL- CAUSE MORTALITY AND CARDIOVASCULAR OUTCOMES Ercan Ok, Izmir, Turkey
EFFECT OF ONLINE HAEMODIAFILTRATION ON ALL- CAUSE MORTALITY AND CARDIOVASCULAR OUTCOMES Ercan Ok, Izmir, Turkey Chair: Walter H. Hörl, Vienna, Austria Wojciech Zaluska, Lublin, Poland Prof Ercan Ok Division
More informationThe CARI Guidelines Caring for Australians with Renal Impairment. Level of renal function at which to initiate dialysis GUIDELINES
Level of renal function at which to initiate dialysis Date written: September 2004 Final submission: February 2005 GUIDELINES No recommendations possible based on Level I or II evidence SUGGESTIONS FOR
More informationOn-line hemodiafiltration and high-flux hemodialysis: comparison of efficiency and cost analysis
Hong Kong Journal J Nephrol of 2001;3(1):21-26. Nephrology 2001;3(1):21-26. HL TANG, et al ORIGINAL A R T I C L E On-line hemodiafiltration and high-flux hemodialysis: comparison of efficiency and cost
More informationThe ultrafiltration coefficient of a dialyser (KUF) is not a fixed value, and it follows a parabolic function: the new concept of KUF max *
Nephrol Dial Transplant (1) 1 of 5 doi: 1.193/ndt/gfq51 NDT Advance Access published September 8, 1 Original Article The ultrafiltration coefficient of a dialyser (KUF) is not a fixed value, and it follows
More informationSodium removal during pre-dilution haemofiltration
Nephrol Dial Transplant (2003) 18 [Suppl 7]: vii31 vii36 DOI: 10.1093/ndt/gfg1076 Sodium removal during pre-dilution haemofiltration Salvatore Di Filippo, Celestina Manzoni, Simeone Andrulli, Francesca
More informationHemodiafiltration: principles and advantages over conventional HD. Rukshana Shroff Great Ormond Street Hospital for Children London, UK
Hemodiafiltration: principles and advantages over conventional HD Rukshana Shroff Great Ormond Street Hospital for Children London, UK Effectiveness of RRT modalities Mcfarlane, Seminars in dialysis, 2009
More informationβ-trace protein is highly removed during haemodialysis with high-flux and super high-flux membranes
Donadio et al. BMC Nephrology (2017) 18:68 DOI 10.1186/s12882-017-0489-6 RESEARCH ARTICLE Open Access β-trace protein is highly removed during haemodialysis with high-flux and super high-flux membranes
More informationPRESERVATION OF RESIDUAL RENAL FUNCTION IN DIALYSIS PATIENTS: EFFECTS OF DIALYSIS-TECHNIQUE RELATED FACTORS
Peritoneal Dialysis International, Vol. 21, pp. 52 57 Printed in Canada. All rights reserved. 0896-8608/00 $3.00 +.00 Copyright 2001 International Society for Peritoneal Dialysis PRESERVATION OF RESIDUAL
More informationThe CARI Guidelines Caring for Australians with Renal Impairment. Blood urea sampling methods GUIDELINES
Date written: November 2004 Final submission: July 2005 Blood urea sampling methods GUIDELINES No recommendations possible based on Level I or II evidence SUGGESTIONS FOR CLINICAL CARE (Suggestions are
More informationKinetics and dosing predictions for daily haemofiltration
Nephrol Dial Transplant (2003) 18: 769 776 DOI: 10.1093/ndt/gfg019 Original Article Kinetics and dosing predictions for daily haemofiltration John K. Leypoldt 1, Bertrand L. Jaber 2, Michael J. Lysaght
More informationResults. Modifiable factors for achieving high-volume HDF
IJAO ISSN 0391-3988 Int J Artif Organs 2015; 38 (5): 244-250 DOI: 10.5301/ijao.5000414 ORIGINAL ARTICLE Modifiable factors associated with achievement of high-volume post-dilution hemodiafiltration: results
More informationThe greatest benefit of peritoneal dialysis (PD) is the
Peritoneal Dialysis International, Vol. 26, pp. 150 154 Printed in Canada. All rights reserved. 0896-8608/06 $3.00 +.00 Copyright 2006 International Society for Peritoneal Dialysis COMBINATION THERAPY
More informationContinuous Renal Replacement Therapy. Gregory M. Susla, Pharm.D., F.C.C.M. Associate Director, Medical Information MedImmune, LLC Gaithersburg, MD
Continuous Renal Replacement Therapy Gregory M. Susla, Pharm.D., F.C.C.M. Associate Director, Medical Information MedImmune, LLC Gaithersburg, MD 1 Definition of Terms SCUF - Slow Continuous Ultrafiltration
More informationContinuous Renal Replacement Therapy
Continuous Renal Replacement Therapy Gregory M. Susla, Pharm.D., F.C.C.M. Associate Director, Medical Information MedImmune, LLC Gaithersburg, MD Definition of Terms SCUF - Slow Continuous Ultrafiltration
More informationNephrology Dialysis Transplantation
Nephrol Dial Transplant (000) 15 [Suppl 1]: 43 48 Nephrology Dialysis Transplantation On-line haemodiafiltration versus low-flux haemodialysis. A prospective randomized study V. Wizemann1, C. Lotz1, F.
More informationTHE HEMODIALYSIS PRESCRIPTION: TREATMENT ADEQUACY GERALD SCHULMAN MD VANDERBILT UNIVERSITY MEDICAL SCHOOL NASHVILLE, TENNESSEE
THE HEMODIALYSIS PRESCRIPTION: TREATMENT ADEQUACY GERALD SCHULMAN MD VANDERBILT UNIVERSITY MEDICAL SCHOOL NASHVILLE, TENNESSEE THE DIALYSIS CYCLE /TIME DESIGN OF THE NATIONAL COOPERATIVE DIALYSIS STUDY
More informationCITRATE DIALYSIS FLUID
CITRATE DIALYSIS FLUID Making possible personal. A CITRATE CONTAINING DIALYSIS FLUID FREE OF ACETATE The Gambro SoftPac concentrate is a citrate-containing, acetate-free concentrate developed by Gambro
More informationModes of Extracorporeal Therapies For ESRD Patients
Modes of Extracorporeal Therapies For ESRD Patients Suhail, MD Extracorporeal Therapies: Dialytic Therapies Dialysis: Movement of molecules across a semipermeable membrane (Bi-directional) Movement of
More informationWe are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors
We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 3,800 116,000 120M Open access books available International authors and editors Downloads Our
More informationOn-line mixed hemodiafiltration with a feedback for ultrafiltration control: Effect on middle-molecule removal
Kidney International, Vol. 64 (2003), pp. 1505 1513 On-line mixed hemodiafiltration with a feedback for ultrafiltration control: Effect on middle-molecule removal LUCIANO A. PEDRINI and VINCENZO DE CRISTOFARO
More informationDeterminants of haemodialyser performance and the potential effect on clinical outcome
Nephrol Dial Transplant 2001) 16 wsuppl 5x: 56±60 Determinants of haemodialyser performance and the potential effect on clinical outcome William R. Clark 1,2 and Claudio Ronco 3 1 Renal Division, Baxter
More informationHemodialysis is a life-sustaining procedure for the treatment of
The Dialysis Prescription and Urea Modeling Biff F. Palmer Hemodialysis is a life-sustaining procedure for the treatment of patients with end-stage renal disease. In acute renal failure the procedure provides
More informationRENAL. Cellentia -H. Cellulose triacetate, single-use, hollow-fiber, high-flux hemodialyzer.
RENAL Cellentia -H Cellulose triacetate, single-use, hollow-fiber, high-flux hemodialyzer www.nipro.com Confidence from the inside out 30 R & D Industry expertise Trusted worldwide Innovative solutions
More informationAna Paula Bernardo. CHP Hospital de Santo António ICBAS/ Universidade do Porto
Ana Paula Bernardo CHP Hospital de Santo António ICBAS/ Universidade do Porto Clinical relevance of hyperphosphatemia Phosphate handling in dialysis patients Phosphate kinetics in PD peritoneal phosphate
More informationA study of a comprehensive medical intervention including a dietary component in elderly patients on hemodialysis
Medical Hong Kong intervention Journal of in Nephrology hemodialysis patients 2001;3(2):84-88. ORIGINAL A R T I C L E A study of a comprehensive medical intervention including a dietary component in elderly
More informationUltrafiltration rate as a dose surrogate in pre-dilution hemofiltration
The International Journal of Artificial Organs / Vol. 30 / no. 2, 2007 / pp. 124-132 Artificial Kidney and Dialysis Ultrafiltration rate as a dose surrogate in pre-dilution hemofiltration Z. HUANG 1, J.J.
More informationCRRT for the Experience User 1. Claudio Ronco, M.D. David Selewski, M.D. Rolando Claure-Del Granado, M.D. AKI & CRRT Conference March, 2018
CRRT for the Experience User 1 Claudio Ronco, M.D. David Selewski, M.D. Rolando Claure-Del Granado, M.D. AKI & CRRT Conference March, 2018 Disclosures I have no actual or potential conflict of interest
More informationObjectives. Peritoneal Dialysis vs. Hemodialysis 02/27/2018. Peritoneal Dialysis Prescription and Adequacy Monitoring
Peritoneal Dialysis Prescription and Adequacy Monitoring Christine B. Sethna, MD, EdM Division Director, Pediatric Nephrology Cohen Children s Medical Center Associate Professor Hofstra Northwell School
More informationThe CARI Guidelines Caring for Australians with Renal Impairment. Other criteria for starting dialysis GUIDELINES
Date written: September 2004 Final submission: February 2005 Other criteria for starting dialysis GUIDELINES No recommendations possible based on Level I or II evidence SUGGESTIONS FOR CLINICAL CARE (Suggestions
More informationHaemodialysis Advanced Therapy System The next generation in haemodialysis
Haemodialysis 58 Advanced Therapy System The next generation in haemodialysis HD patients are at risk of increased CVD mortality and morbidity One in two dialysis patients die of CVD 8 1 Healthcare providers
More informationTreated ESRD Incidence Rate for Selected Countries, New Patients/Million Pop. 250 USA (All) USRDS 1996
Annual Data Report International Comparisons of ESRD Therapy Chapter XI International Comparisons of ESRD Therapy O ver the last decade a growing number of national and regional registries dealing with
More informationClinical significance of protein adsorbable membranes Long-term clinical effects and analysis using a proteomic technique
Nephrol Dial Transplant (27) 22 [Suppl ]: v13 v19 doi:1.193/ndt/gfm29 Clinical significance of protein adsorbable membranes Long-term clinical effects and analysis using a proteomic technique Ikuo Aoike
More informationIN THE NAME OF GOD Uremic toxins I. Small (< 500 D); water soluble Surrogate marker urea or sodium (ionic dialysance) Rapidly produced in intracellular fluid compartment Large variability in intra-patient
More informationCan We Achieve Precision Solute Control with CRRT?
Can We Achieve Precision Solute Control with CRRT? Claudio Ronco, M.D. David Selewski, M.D. Rolando Claure-Del Granado, M.D. AKI & CRRT Conference February, 2019 Disclosures I have no actual or potential
More informationOriginal Article. Introduction
Nephrol Dial Transplant (2004) 19: 100 107 DOI: 10.1093/ndt/gfg418 Original Article Haemodialysis prescription, adherence and nutritional indicators in five European countries: results from the Dialysis
More informationMixed predilution and postdilution online hemodiafiltration compared with the traditional infusion modes
Kidney International, Vol. 58 (2000), pp. 2155 2165 Mixed predilution and postdilution online hemodiafiltration compared with the traditional infusion modes LUCIANO A. PEDRINI, VINCENZO DE CRISTOFARO,
More informationThe clearance of protein-bound solutes by hemofiltration and hemodiafiltration
The clearance of protein-bound solutes by hemofiltration and hemodiafiltration TIMOTHY W. MEYER,JASON L. WALTHER, MARIA ENRICA PAGTALUNAN, ANDRES W. MARTINEZ, ALI TORKAMANI,PATRICK D. FONG,NATALIE S. RECHT,
More informationThe kidneys maintain the body s homeostasis by
Rationale for Daily Dialysis Umberto Buoncristiani, Riccardo Fagugli, Giuseppe Quintaliani, Hrissanti Kulurianu Nephrology-Dialysis Unit, Ospedale Regionale, Perugia, Italy. The kidneys maintain the body
More informationHaemodialysis. The AutoFlow Function for the 5008 Therapy System Optimising the Dialysis Fluid Flow Rate
Haemodialysis The AutoFlow Function for the 5008 Therapy System Optimising the Dialysis Fluid Flow Rate 2 The Dialysis Fluid Flow Rate In current dialysis practice, a dialysis fluid flow rate of either
More informationHaemodialysis. 4008S Visually the best dialysis results
Haemodialysis 4008S Visually the best dialysis results Therapy Through continuous optimisation of the treatment modalities Fresenius Medical Care always aims to offer patients the best renal replacement
More informationHaemodialysis Machines H/S Visually the best dialysis results
Haemodialysis Machines 4008 H/S Visually the best dialysis results Therapy Through continuous optimisation of the treatment modalities Fresenius Medical Care always aims to offer patients the best renal
More informationHemodialysis Adequacy: A Complex and Evolving Paradigm. Balazs Szamosfalvi, MD Monday, 08/30/ :00-09:45
Hemodialysis Adequacy: A Complex and Evolving Paradigm Balazs Szamosfalvi, MD Monday, 08/30/2010 09:00-09:45 Adequacy 1943-1970 Fresenius The patient survived the dialysis session Uremia improved Volume
More informationBrief communication (Original)
Asian Biomedicine Vol. 8 No. 1 February 2014; 67-73 DOI: 10.5372/1905-7415.0801.263 Brief communication (Original) Long-term clinical effects of treatment by daytime ambulatory peritoneal dialysis with
More informationPeritoneal Dialysis Adequacy: Not Just Small- Solute Clearance
Advances in Peritoneal Dialysis, Vol. 24, 2008 Rajesh Yalavarthy, Isaac Teitelbaum Peritoneal Dialysis Adequacy: Not Just Small- Solute Clearance Two indices of small-solute clearance, Kt/V urea and creatinine
More informationDialysis Dose Prescription and Delivery. William Clark, M.D. Claudio Ronco, M.D. Rolando Claure-Del Granado, M.D. CRRT Conference February 15, 2012
Dialysis Dose Prescription and Delivery William Clark, M.D. Claudio Ronco, M.D. Rolando Claure-Del Granado, M.D. CRRT Conference February 15, 2012 Dose in RRT: Key concepts Dose definition Quantifying
More informationThe Egyptian Journal of Hospital Medicine (Apr. 2017) Vol.67 (2), Page
The Egyptian Journal of Hospital Medicine (Apr. 2017) Vol.67 (2), Page 645-655 Effects of High Flux versus Low Flux on Serum C-Reactive Protein A as an Inflammatory Biomarker in Hemodialysis Patients Emad
More informationTREATMENT SAFETY AND EFFECTIVENESS CONTROL OF MODERN DIALYSIS MACHINES
TREATMENT SAFETY AND EFFECTIVENESS CONTROL OF MODERN DIALYSIS MACHINES Sarajevo, October 5 th, 2017 Modern dialysis machines have evolved from the early cumbersome and inefficient devices to those with
More informationManaging Acid Base and Electrolyte Disturbances with RRT
Managing Acid Base and Electrolyte Disturbances with RRT John R Prowle MA MSc MD MRCP FFICM Consultant in Intensive Care & Renal Medicine RRT for Regulation of Acid-base and Electrolyte Acid base load
More informationUltrapure dialysis fluid slows loss of residual renal function in new dialysis patients
Nephrol Dial Transplant (2002) 17: 1814 1818 Original Article Ultrapure dialysis fluid slows loss of residual renal function in new dialysis patients Helmut Schiffl 1, Susanne M. Lang 2 and Rainald Fischer
More informationA reliable method to assess the water permeability of a dialysis system: the global ultrafiltration coefficient *
Nephrol Dial Transplant (2017) 32: 364 370 doi: 10.1093/ndt/gfw370 Advance Access publication 10 November 2016 A reliable method to assess the water permeability of a dialysis system: the global ultrafiltration
More informationOlistic Approach to Treatment Adequacy in AKI
Toronto - Canada, 2014 Olistic Approach to Treatment Adequacy in AKI Claudio Ronco, MD Department of Nephrology, St. Bortolo Hospital, International Renal Research Institute Vicenza - Italy 1) RRT
More informationThe Effect of High-Flux Hemodialysis on Dialysis-Associated Amyloidosis
Renal Failure, 1:31-34, 2005 Copyright 2005 Taylor & Francis Inc. ISSN: 0886-022X print / 1525-6049 online DOI: 10.1081/JDI-200042868 Taylor & Francis Taylor 6. Francis Croup CLINICAL STUDY The Effect
More informationUraemic itching: do polymethylmethacrylate dialysis membranes play a role?
Nephrol Dial Transplant (2007) 22 [Suppl 5]: v8 v12 doi:10.1093/ndt/gfm293 Uraemic itching: do polymethylmethacrylate dialysis membranes play a role? Filippo Aucella 1,2, Mimmo Vigilante 1, Antonio Gesuete
More informationLLL Session - Nutritional support in renal disease
ESPEN Congress Leipzig 2013 LLL Session - Nutritional support in renal disease Peritoneal dialysis D. Teta (CH) Nutrition Support in Patients undergoing Peritoneal Dialysis (PD) Congress ESPEN, Leipzig
More informationCRRT. Sustained low efficiency daily dialysis, SLEDD. Sustained low efficiency daily diafiltration, SLEDD-f. inflammatory cytokine IL-1 IL-6 TNF-
RRT, renal replacement therapy IHDCRRT CRRT 24 CRRT Sustained low efficiency daily dialysis, SLEDD 6 ~ 12 300 Sustained low efficiency daily diafiltration, SLEDD-f inflammatory cytokine IL-1 IL-6 TNF-
More informationEffect of increasing dialysate flow rate on diffusive mass transfer of urea, phosphate and β 2 -microglobulin during clinical haemodialysis
Nephrol Dial Transplant (2010) 25: 3990 3995 doi: 10.1093/ndt/gfq326 Advance Access publication 13 June 2010 Original Articles Effect of increasing dialysate flow rate on diffusive mass transfer of urea,
More informationHigh-quality dialysis: a lesson from the Japanese experience
NDT Plus (21) 3 [Suppl 1]: i28 i35 doi: 1.193/ndtplus/sfq34 High-quality dialysis: a lesson from the Japanese experience Ikuto Masakane Yabuki Shima Clinic, Yamagata, Japan Correspondence and offprint
More informationThe Effect of Residual Renal Function at the Initiation of Dialysis on Patient Survival
ORIGINAL ARTICLE DOI: 10.3904/kjim.2009.24.1.55 The Effect of Residual Renal Function at the Initiation of Dialysis on Patient Survival Seoung Gu Kim 1 and Nam Ho Kim 2 Department of Internal Medicine,
More informationIn vivo clearance and elimination of nine marker substances during hemofiltration with different membranes
The International Journal of Artificial Organs / Vol. 15 / no. 7, 1992 / pp. 408-412 Artificial Kidney and Dialysis In vivo clearance and elimination of nine marker substances during hemofiltration with
More information- SLED Sustained Low-Efficiency Dialysis
Continuous Renal Replacement Therapy Gregory M. Susla, Pharm.D., F.C.C.M. Associate Director, Medical Information MedImmune, LLC Gaithersburg, MD 1 Definition of Terms - SCUF - Slow Continuous Ultrafiltration
More informationInfluence of convection on small molecule clearances in online hemodiafiltration Technical Note
Kidney International, Vol. 57 (2000), pp. 1755 1763 Influence of convection on small molecule clearances in online hemodiafiltration Technical Note ALAIN FICHEUX, ÀNGEL ARGILÉS, HENRI MION, and CHARLES
More informationThe CARI Guidelines Caring for Australians with Renal Impairment. Peritoneal transport and ultrafiltration GUIDELINES
Date written: January 2004 Final submission: May 2004 Peritoneal transport and ultrafiltration GUIDELINES No recommendations possible based on Level I or II evidence SUGGESTIONS FOR CLINICAL CARE (Suggestions
More informationegfr 34 ml/min egfr 130 ml/min Am J Kidney Dis 2002;39(suppl 1):S17-S31
Update on Renal Therapeutics Caroline Ashley Lead Pharmacist Renal Services UCL Centre for Nephrology, Royal Free Hospital, London Kongress für Arzneimittelinformation January 2011 What are we going to
More informationAdequacy of haemodialysis and nutrition in maintenance haemodialysis patients: clinical evaluation of a new on-line urea monitor
Nephrol Dial Transplant (1996) 11: 1568-1573 Original Article IMephrology Dialysis Transplantation Adequacy of haemodialysis and nutrition in maintenance haemodialysis patients: clinical evaluation of
More information